Juncture Wealth Strategies »

Aurinia Pharmaceuticals shares owned by Juncture Wealth Strategies

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Juncture Wealth Strategies from 13F filings

Historical chart of Juncture Wealth Strategies investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Juncture Wealth Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Juncture Wealth Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $150k 10k 14.82

More positions owned by Juncture Wealth Strategies

Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust State Street Spd (SPYV)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Global X Fds S&p 500 Covered (XYLD)
Global X Fds Global X Uranium (URA)
Invesco Exchange Traded Fd T Aerospace Defn (PPA)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ishs 1-5yr Invs (IGSB)

View all positions for Juncture Wealth Strategies

Top funds holding Aurinia Pharmaceuticals

Tang Capital Management
BlackRock
NEA Management Company
Two Sigma Investments
Arrowstreet Capital, Limited Partnership
State Street Corporation
Morgan Stanley
Renaissance Technologies
Marshall Wace
D. E. Shaw & Co
Geode Capital Management
Vanguard Group
Goldman Sachs Group
Vanguard Portfolio Management
Jacobs Levy Equity Management

View all funds holding Aurinia Pharmaceuticals